1220.48.1012 Boehringer Ingelheim Investigational Site

Edmonton, Alberta

0 studies enrolling now · 1 studies all time

What they study most

Hepatitis C

Studies at this site

• A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients — Completed